Serine protease inhibitors
US5550139A · kind A · utility
28Cited by
2References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 3, 1994 |
| Grant date | Aug 27, 1996 |
| Priority date | — |
| Expiry date | Jan 3, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6539
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Isothiazolidin-3-one-1,1 dioxide, 3-oxo-1,2,5-thiadiazolidine-1,1,-dioxide and derivatives thereof, reduce or inhibit the activity of serine proteases. Such compounds are useful as anti-inflammatory and anti-metastatic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.